Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5412)
All Articles published online
|
Dec 21, 2006 (publication date) through Dec 2, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Hanai H. Positions of selective leukocytapheresis in the medical therapy of ulcerative colitis. World J Gastroenterol 2006; 12(47): 7568-7577 [PMID: 17171783 DOI: 10.3748/wjg.v12.i47.7568] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v12/i47/7568.htm |
| Number | Citing Articles |
| 1 |
Abbi R. Saniabadi, Hiroyuki Hanai, Ken Fukunaga, Koji Sawada, Chikako Shima, Ingvar Bjarnason, Robert Lofberg. Therapeutic leukocytapheresis for inflammatory bowel disease. Transfusion and Apheresis Science 2007; 37(2): 191 doi: 10.1016/j.transci.2007.08.003
|
| 2 |
J. L. Cabriada, E. Domènech, N. Ibargoyen, V. Hernández, J. Clofent, D. Ginard, I. Gutiérrez-Ibarluzea, J. Hinojosa. Leukocytapheresis for steroid-dependent ulcerative colitis in clinical practice: results of a nationwide Spanish registry. Journal of Gastroenterology 2012; 47(4): 359 doi: 10.1007/s00535-011-0499-2
|
| 3 |
M. Edinger. CD4+ CD25+ regulatory T cells approach the clinic. Cytotherapy 2008; 10(7): 655 doi: 10.1080/14653240802492705
|
| 4 |
Masahiro Iizuka, Shiho Sagara, Takeshi Etou. Efficacy of long-interval cytapheresis on steroid-dependent refractory ulcerative colitis. Inflammatory Bowel Diseases 2011; 17(9): E119 doi: 10.1002/ibd.21786
|
| 5 |
Katsuyuki Tozawa, Ken Fukunaga, Koji Kamikozuru, Kunio Ohnishi, Nobuyuki Hida, Yoshio Ohda, Takeshi Kusaka, Koji Yoshida, Yoshio Jinno, Kazuko Nagase, Shirou Nakamura, Hiroto Miwa, Takayuki Matsumoto. Hyperthermic stimulation of blood increases the immunological effects of granulocyte and monocyte adsorption in vitro: Relevance to extracorporeal immunomodulation. Transfusion and Apheresis Science 2008; 39(2): 129 doi: 10.1016/j.transci.2008.07.012
|
| 6 |
Emilio Cuadrado, Marta Alonso, Maria Dolores de Juan, Pilar Echaniz, Juan Ignacio Arenas. Regulatory T cells in patients with inflammatory bowel diseases treated with adacolumn granulocytapheresis. World Journal of Gastroenterology 2008; 14(10): 1521-1527 doi: 10.3748/wjg.14.1521
|
| 7 |
Caroline Schultheiß, René Weischenberg, Andrea Herrmann, Bernhard Haller, Roland M. Schmid, Wolfgang Reindl, Wolfgang Huber. Dose‐Intensified Granulocyte‐Monocyte Apheresis in Therapy Refractory Ulcerative Colitis. Artificial Organs 2015; 39(2): 187 doi: 10.1111/aor.12329
|
| 8 |
A. U. DIGNASS, A. ERIKSSON, A. KILANDER, A. PUKITIS, J. M. RHODES, S. VAVRICKA. Clinical trial: five or ten cycles of granulocyte–monocyte apheresis show equivalent efficacy and safety in ulcerative colitis. Alimentary Pharmacology & Therapeutics 2010; 31(12): 1286 doi: 10.1111/j.1365-2036.2010.04295.x
|
| 9 |
Gerda C Leitner, Harald Vogelsang. Pharmacological- and non-pharmacological therapeutic approaches in inflammatory bowel disease in adults. World Journal of Gastrointestinal Pharmacology and Therapeutics 2016; 7(1): 5-20 doi: 10.4292/wjgpt.v7.i1.5
|
| 10 |
Masahiro Iizuka, Takeshi Etou, Makoto Kumagai, Atsushi Matsuoka, Yuka Numata, Shiho Sagara. Long-interval Cytapheresis as a Novel Therapeutic Strategy Leading to Dosage Reduction and Discontinuation of Steroids in Steroid-dependent Ulcerative Colitis. Internal Medicine 2017; 56(20): 2705 doi: 10.2169/internalmedicine.8428-16
|
| 11 |
Esteban Sáez-González, Inés Moret, Diego Alvarez-Sotomayor, Francia Carolina Díaz-Jaime, Elena Cerrillo, Marisa Iborra, Pilar Nos, Belén Beltrán. Immunological Mechanisms of Adsorptive Cytapheresis in Inflammatory Bowel Disease. Digestive Diseases and Sciences 2017; 62(6): 1417 doi: 10.1007/s10620-017-4577-z
|
| 12 |
Xiu-Li Chen, Jing-Wei Mao, Ying-De Wang. Selective granulocyte and monocyte apheresis in inflammatory bowel disease: Its past, present and future. World Journal of Gastrointestinal Pathophysiology 2020; 11(3): 43-56 doi: 10.4291/wjgp.v11.i3.43
|
| 13 |
Emilio Cuadrado. Granulocyte/monocyte apheresis as immunotherapic tool: Cellular adsorption and immune modulation. Autoimmunity Reviews 2009; 8(4): 292 doi: 10.1016/j.autrev.2008.09.001
|
| 14 |
Hiroyuki Hanai. Leucocytapheresis for inflammatory bowel disease in the era of biologic therapy. European Journal of Gastroenterology & Hepatology 2008; 20(7): 596 doi: 10.1097/MEG.0b013e3282f5e9f3
|
| 15 |
Valeria D'Ovidio, Donatella Meo, Maria Gozer, Marco E. Bazuro, Piero Vernia. Ulcerative colitis and granulocyte-monocyte-apheresis: Safety and efficacy of maintenance therapy during pregnancy. Journal of Clinical Apheresis 2015; 30(1): 55 doi: 10.1002/jca.21349
|
| 16 |
Gerardo Prieto Bozano. Granulocitoféresis en la colitis ulcerosa. Anales de Pediatría Continuada 2012; 10(5): 286 doi: 10.1016/S1696-2818(12)70100-2
|
| 17 |
Jose L. Cabriada, Nora Ibargoyen, Anaiansi Hernández, Antonio Bernal, Agustín Castiella. Sustained remission after steroids and leukocytapheresis induced response in steroid-dependent ulcerative colitis: Results at 1 year. Digestive and Liver Disease 2010; 42(6): 432 doi: 10.1016/j.dld.2009.09.001
|
| 18 |
José Luis Cabriada. Aféresis en enfermedad inflamatoria intestinal. ¿Una opción válida?. Gastroenterología y Hepatología 2012; 35(1): 22 doi: 10.1016/j.gastrohep.2011.10.005
|
| 19 |
T. Yamamoto, A.R. Saniabadi, Y. Maruyama, S. Umegae, K. Matsumoto. Factors affecting clinical and endoscopic efficacies of selective leucocytapheresis for ulcerative colitis. Digestive and Liver Disease 2007; 39(7): 626 doi: 10.1016/j.dld.2007.04.007
|
| 20 |
Tomotaka Tanaka, Takayuki Yamamoto, Koji Sawada, Rodolfo Sacco. Treatment options for children and adolescents with inflammatory bowel disease: is granulomonocytapheresis an effective alternative to drug therapy?. Expert Review of Gastroenterology & Hepatology 2017; 11(8): 749 doi: 10.1080/17474124.2017.1341309
|
| 21 |
Javier Martín de Carpi, Pere Vilar, Gerardo Prieto, María Dolores García Novo, Carmen Ribes, Vicente Varea. Safety and Efficacy of Granulocyte and Monocyte Adsorption Apheresis in Paediatric Inflammatory Bowel Disease: A Prospective Pilot Study. Journal of Pediatric Gastroenterology and Nutrition 2008; 46(4): 386 doi: 10.1097/MPG.0b013e31815604e5
|
| 22 |
K Kamikozuru, K Fukunaga, S Hirota, N Hida, Y Ohda, K Yoshida, Y Yokoyama, K Tozawa, K Kawa, M Iimuro, K Nagase, A R Saniabadi, S Nakamura, H Miwa, T Matsumoto. The expression profile of functional regulatory T cells, CD4+CD25high+/forkhead box protein P3+, in patients with ulcerative colitis during active and quiescent disease. Clinical and Experimental Immunology 2009; 156(2): 320 doi: 10.1111/j.1365-2249.2009.03904.x
|
| 23 |
Bailu Duan, Qiong Hu, Fengmin Ding, Fang Huang, Wei Wang, Nina Yin, Zhe Liu, Song Zhang, Dongchu He, Qiping Lu. The effect and mechanism of Huangqin-Baishao herb pair in the treatment of dextran sulfate sodium-induced ulcerative colitis. Heliyon 2023; 9(12): e23082 doi: 10.1016/j.heliyon.2023.e23082
|
| 24 |
Takuji Tanaka, Mariangela B.M. de Azevedo, Nelson Durán, Joel B. Alderete, Francesco Epifano, Salvatore Genovese, Mayu Tanaka, Takahiro Tanaka, Massimo Curini. Colorectal cancer chemoprevention by 2 β‐cyclodextrin inclusion compounds of auraptene and 4′‐geranyloxyferulic acid. International Journal of Cancer 2010; 126(4): 830 doi: 10.1002/ijc.24833
|
| 25 |
J. Muñoz, M. Clavo, O. Garcia, D. Reina, A. Vidaller, R. Lafuente, L. I. Massuet. Adsorptive monocyte and granulocyte apheresis in the chronic inflammatory illness: ulcerous colitis, Crohn's disease, rheumatoid arthritis and Behcet syndrome. ISBT Science Series 2007; 2(1): 96 doi: 10.1111/j.1751-2824.2007.00067.x
|
| 26 |
Jacqueline Van De Walle, Béatrice Romier, Yvan Larondelle, Yves-Jacques Schneider. Influence of deoxynivalenol on NF-κB activation and IL-8 secretion in human intestinal Caco-2 cells. Toxicology Letters 2008; 177(3): 205 doi: 10.1016/j.toxlet.2008.01.018
|
| 27 |
H. Hanai, T. Iida, K. Takeuchi, F. Watanabe, Y. Maruyama, M. Kageoka, K. Ikeya, M. Yamada, M. Kikuyama, Y. Iwaoka, K. Hirayama, S. Nagata, Y. Sato, Y. Hosoda. Intensive granulocyte and monocyte adsorption versus intravenous prednisolone in patients with severe ulcerative colitis: An unblinded randomised multi-centre controlled study. Digestive and Liver Disease 2008; 40(6): 433 doi: 10.1016/j.dld.2008.01.007
|
| 28 |
Ken Fukunaga, Kazuko Nagase, Takeshi Kusaka, Nobuyuki Hida, Yoshio Ohda, Koji Yoshida, Katsuyuki Tozawa, Koji Kamikozuru, M Iimuro, Shiro Nakamura, Hiroto Miwa, Takayuki Matsumoto. Cytapheresis in Patients with Severe Ulcerative Colitis after Failure of Intravenous Corticosteroid: A Long-Term Retrospective Cohort Study. Gut and Liver 2009; 3(1): 41 doi: 10.5009/gnl.2009.3.1.41
|
| 29 |
Abbi R Saniabadi, Tomotaka Tanaka, Toshihide Ohmori, Koji Sawada, Takayuki Yamamoto, Hiroyuki Hanai. Treating inflammatory bowel disease by adsorptive leucocytapheresis: A desire to treat without drugs. World Journal of Gastroenterology 2014; 20(29): 9699-9715 doi: 10.3748/wjg.v20.i29.9699
|
| 30 |
Fridrik Thor Sigurbjörnsson, Ingvar Bjarnason. Leukocytapheresis for the treatment of IBD. Nature Clinical Practice Gastroenterology & Hepatology 2008; 5(9): 509 doi: 10.1038/ncpgasthep1209
|
| 31 |
Hiroyuki Hanai, Takayuki Iida, Ken Takeuchi, Fumitoshi Watanabe, Masami Yamada, Masataka Kikuyama, Yasushi Maruyama, Yasushi Iwaoka, Kazuhisa Hirayama, Seiji Nagata, Kenji Takai. Adsorptive Depletion of Elevated Proinflammatory CD14+CD16+DR++Monocytes in Patients With Inflammatory Bowel Disease. The American Journal of Gastroenterology 2008; 103(5): 1210 doi: 10.1111/j.1572-0241.2007.01714.x
|
| 32 |
Reikei Matsuda, Tomoko Koide, Chikako Tokoro, Tsuyoshi Yamamoto, Tenʼi Godai, Taiki Morohashi, Yuji Fujita, Daisuke Takahashi, Ichiro Kawana, Shinichiro Suzuki, Satoshi Umemura. Quantitive Cytokine mRNA Expression Profiles in the Colonic Mucosa of Patients with Steroid Naïve Ulcerative Colitis During Active and Quiescent Disease. Inflammatory Bowel Diseases 2009; 15(3): 328 doi: 10.1002/ibd.20759
|
| 33 |
R. Ravasio, G. De Silvestro, A. Saggioro, G. C. Sturniolo, P. Vernia. Valutazione economica del sistema di aferesi per la rimozione di granulociti e macrofagi (Adacolumn®) rispetto a biologico nel trattamento della colite ulcerosa moderata-severa in pazienti steroido-dipendenti o resistenti in Italia. Giornale Italiano di Health Technology Assessment 2013; 6(2-3): 55 doi: 10.1007/s40269-013-0008-y
|
| 34 |
Piero Vernia, Valeria D’Ovidio, Donatella Meo. Leukocytapheresis in the treatment of inflammatory bowel disease: Current position and perspectives. Transfusion and Apheresis Science 2010; 43(2): 227 doi: 10.1016/j.transci.2010.07.023
|